Artivest Publishes New Whitepaper on Legal Cannabis Industry for Investors and Advisors

Written by Shared Content

NEW YORK and SAN DIEGO, Nov. 14, 2018 /PRNewswire/ — With American voters easing cannabis regulations in Michigan, Missouri, and Utah on November 6th, 33 states have now legalized cannabis for either recreational or medical use.

As the legal cannabis industry continues its expansion across the U.S. (the world’s largest market for cannabis sales), Artivest has published a new whitepaper entitled “Five Things Every Cannabis Investor Needs to Know.” This 16-page research paper, written by Matt Osborne, Artivest’s Chief Investment Officer, provides investment professionals and suitable investors with a comprehensive overview of this new global industry. Artivest invites these audiences to register online to receive this whitepaper at  

“Growing public acceptance of cannabis, exhaustion with the prosecution of anti-[cannabis] laws, and increased interest in cannabis as an alternative to the opioid epidemic have positioned this industry for growth,” said Matt Osborne. “As with any emerging industry, however, individual investors must carefully evaluate appropriate investment offerings with their advisors.”

Examples of data points and findings presented in this whitepaper include:

  • Americans’ support for cannabis legalization now stands at 64% (according to Gallup), the highest level in nearly half a century.
  • Legal cannabis retail sales reached an all-time record of $9.5 billion in 2017, with the U.S. generating $8.5 billion or 90% of worldwide revenue.
  • Consumer equity research analysts are forecasting that legal cannabis retail sales will reach $75 billion by 2030.
  • Cannabis-derived pharmaceuticals and nutraceuticals are forecast to surpass $100 billion in sales by 2025, according to leading health care equity analysts.

Osborne adds, “We hope investors and advisors will utilize the information in this whitepaper to effectively navigate the legal cannabis investing landscape.”

About Artivest
Artivest is the premier alternative investment platform, offering investors and advisors digital access to institutional-quality alternative strategies, including private equity, hedge funds, managed futures, and real assets. Our enterprise solutions for asset and wealth managers include information delivery and transaction processing, investment research and product structuring, and national distribution. Artivest remains privately held by its employees and outside investors, led by KKR, Thiel Capital, Genstar Capital, and Aquiline Capital Partners. For more information, please visit

Special Considerations Regarding Investments in the Cannabis Industry
If you are considering a cannabis industry, marijuana-related investment, you should be aware of the risk of investment fraud and market manipulation. Investment promoters may be unlicensed and unregistered, and therefore some of the recourse typically available to investors of registered products may not be available. Investments in the cannabis industry are inherently risky, returns are not guaranteed, and you may lose all or a substantial amount of your investment. Market manipulators may cause stock prices to fluctuate dramatically and this can be more prevalent in microcap stocks due to their lack of transparency and limited liquidity. Be wary of trading suspension, changes to business name and/or type, and implausible press releases. In addition to the risks above, companies engaged in the marijuana business industry could potentially be at risk of criminal prosecution due to the nature of their business. Should this occur, the value of your investment may be materially impacted.

Media Contact
Dana Taormina
JConnelly for Artivest
(973) 850-7305

SOURCE Artivest

About the author

Shared Content

Leave a Comment